Romiplostim

Type: Product
Name: Romiplostim
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Data on Myelodysplastic Syndrome Reported by Researchers at Amgen (Romiplostim dose-response in patients with myelodysplastic syndromes)

By a News Reporter-Staff News Editor at Biotech Week -- Investigators discuss new findings in Myelodysplastic Syndrome. According to news reporting from Barcelona, Spain , by NewsRx journalists, research stated, "To characterize the romiplostim dose-response ... [Published 4 Traders - Jul 09 2014]
First reported Jun 11 2014 - Updated Jun 11 2014 - 1 reports

Opinion/decision on a Paediatric Investigation Plan (PIP): Nplate, Romiplostim, Therapeutic area: Haematology-Hemostaseology

Quotes

According to the news reporters, the research concluded: "The time course of platelet counts in MDS subjects receiving subcutaneous administration of escalating doses of romiplostim was characterized and showed a linear dose-response for romiplostim responders to increase the platelet counts."

More Content

All (3) | News (2) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Data on Myelodysplastic Syndrome Reported by Re... [Published 4 Traders - Jul 09 2014]
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Jun 11 2014]
NOVEL Health Strategies Presenting Ten Peer-Rev... [Published PRWeb - Nov 03 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Jun 11 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.